Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on November 7, 2019. The filing serves to announce the Company's financial results for the fiscal quarter ended September 30, 2019. The detailed results are contained in a press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1) but are not explicitly stated within the body of this 8-K document.
Material Changes
The filing does not provide specific data regarding material changes versus the prior comparable period. It solely indicates that results for the quarter ended September 30, 2019, have been announced.
Guidance, Outlook, and Risks
The text does not include specific guidance, outlook, management commentary, risks, contingencies, or unusual items. The filing explicitly states that the information furnished, including the press release, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that Section, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 7, 2019) for specific revenue, net loss, and cash position figures.
- Verify the Company's status as an emerging growth company and any election regarding extended transition periods for accounting standards.
- Confirm the trading symbol (GH) and exchange (The Nasdaq Stock Market LLC) for the Common Stock.
- Note that the financial data in this 8-K is not deemed "filed" under Section 18 of the Exchange Act.